Following initial service disruptions, as of December 2025, HIV testing, prevention, and treatment are showing early signs of recovery in Mozambique, according to UNAIDS.

Date: 12/25

Region: Africa

Country: Mozambique

Topic: Health

Policy Lens: Global Health Security

Entry Type: Secondary Effect

Additional Context: A health commodities project known as CHEGAR resumed operations under alternative funding arrangements in May 2025; the U.S. government subsequently announced $160 million in PEPFAR Bridge funding in September 2025, intended to sustain Mozambique's HIV response through March 2026. Data for national supply chain adaptation is updated as of May 2025.

Devex Researcher Note: In Mozambique, PEPFAR-supported facilities ran treatments for 82% of people living with HIV. U.S. Data between 2017 and 2022 consistently shows PEPFAR funding upwards of 66% of all HIV-related expenditures in the country. The PEPFAR Bridge funding is intended as a temporary transitional instrument under the America First Global Health Strategy, promoted by the U.S. Department of State, which seeks to restructure U.S. global health assistance around time-bound bilateral agreements with recipient governments, moving away from NGO-led implementation toward direct government-to-government cooperation.

Source: UNAIDS